$FOLD

Amicus Therapeutics Inc.

  • NASDAQ/NMS (GLOBAL MARKET)
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$21.8 ▼-0.16%

Extented Hours

VOLUME

4,221,580

DAY RANGE

21.79 - 23.36

52 WEEK

6.63 - 24.89

Echofin Members Consensus

profile
PradeepB #droscrew Join team
recently

correct but atleast you know if you want to continue to hold it or you want to fold it , this chart helps with that decision

HE
HeyShoe #droscrew Join team
recently

implied fold equity

GM
gman2 #ivtrades Join team
recently

you have to know when to hold 'em, know when to fold 'em, know when to walk away, know when to run, never count your money when you're sitting at the table, they'll be plenty time for counting, when the dealings done. The Gambler.

profile
dros #droscrew Join team
recently

but I think this pop has to revert a bit as vaccine realities come into the fold

HU
Humbleguy #FOREX Join team
recently

just blow on him he'll fold

CO
coulldc #vpatraders Join team
recently

Hi @Mbstok and welcome back to the fold and we are still very much forex focused - we run two webinars at the moment, the one in the morning is the London open and forex specific and we do have futures also but both spot and futures,. Spot markets are just the same as they always have been - we have just added futures to show that VPA applies equally well to both. The second webinar for the US session is more index/

profile
dros #droscrew Join team
recently

$NAV + Traton agreement $HTZ + Commitments secured $MVIS + Patent $CCL + Some sailings resume $UBER + Uber Elevate options $FIT + On track EU approval $VUZI + contract $ACIA - no china rulings yet $EOG + Betaville chatter $FOLD + DealReporter chatter

profile
JB61 #FOREX Join team
recently

I think she will fold like a napkin

profile
BORISDAVTT #FOREX Join team
recently

you know they are gonna fold anyway.. perfect chance to cash out

Key Metrics

Market Cap

5.69 B

Beta

1.40

Avg. Volume

2.43 M

Shares Outstanding

260.59 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

CEO: John Crowley

Website:

HQ: 1 Cedarbrook Dr Cranbury, 08512-3618 New jersey

Related News

  • Benzinga

    Sarepta, Amicus Top Biotech Picks Ahead Of Key Binary Events: Analyst

    18 Dec 2020, 19:00
  • Watchlist News

    Hung Do Sells 111,125 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock

    18 Dec 2020, 10:20
  • Fintech Zoom

    A Look At The Intrinsic Value Of Amicus Therapeutics, Inc. (NASDAQ:FOLD)

    14 Dec 2020, 11:50
  • Benzinga

    The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut

    03 Dec 2020, 12:46
  • Benzinga

    The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted

    18 Nov 2020, 12:29